BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $155 | -99.9% | 3,036 | -4.4% | 0.02% | -8.0% |
Q3 2022 | $171,000 | -25.3% | 3,177 | -10.9% | 0.02% | -32.4% |
Q2 2022 | $229,000 | -32.0% | 3,567 | -17.9% | 0.04% | -22.9% |
Q1 2022 | $337,000 | -12.0% | 4,347 | -2.5% | 0.05% | -9.4% |
Q4 2021 | $383,000 | +2.7% | 4,460 | -3.9% | 0.05% | -5.4% |
Q3 2021 | $373,000 | +1.4% | 4,642 | +1.6% | 0.06% | 0.0% |
Q2 2021 | $368,000 | -6.1% | 4,567 | -1.6% | 0.06% | -12.5% |
Q1 2021 | $392,000 | -6.4% | 4,642 | -11.2% | 0.06% | -12.3% |
Q4 2020 | $419,000 | -5.2% | 5,228 | -4.9% | 0.07% | -15.1% |
Q3 2020 | $442,000 | -27.4% | 5,498 | -22.3% | 0.09% | -33.3% |
Q2 2020 | $609,000 | +2.9% | 7,073 | -3.1% | 0.13% | -25.9% |
Q1 2020 | $592,000 | -5.6% | 7,298 | -2.6% | 0.17% | +17.6% |
Q4 2019 | $627,000 | -6.3% | 7,493 | -2.1% | 0.15% | -12.4% |
Q3 2019 | $669,000 | +5.0% | 7,653 | -1.6% | 0.17% | +2.4% |
Q2 2019 | $637,000 | -5.1% | 7,778 | -5.8% | 0.16% | -8.8% |
Q1 2019 | $671,000 | +13.5% | 8,253 | -8.1% | 0.18% | -1.1% |
Q4 2018 | $591,000 | -19.3% | 8,976 | -5.4% | 0.18% | -7.1% |
Q3 2018 | $732,000 | +2.4% | 9,492 | -1.9% | 0.20% | -4.4% |
Q2 2018 | $715,000 | +2.3% | 9,675 | -10.0% | 0.21% | -2.4% |
Q1 2018 | $699,000 | -4.9% | 10,746 | -5.5% | 0.21% | -1.9% |
Q4 2017 | $735,000 | +0.3% | 11,374 | -2.5% | 0.22% | -6.5% |
Q3 2017 | $733,000 | +0.3% | 11,671 | -3.3% | 0.23% | -3.0% |
Q2 2017 | $731,000 | +16.0% | 12,071 | -0.6% | 0.24% | +10.7% |
Q1 2017 | $630,000 | +21.2% | 12,146 | +3.5% | 0.21% | +16.9% |
Q4 2016 | $520,000 | +4.2% | 11,739 | +11.9% | 0.18% | +1.7% |
Q3 2016 | $499,000 | +22.3% | 10,489 | +16.2% | 0.18% | +20.0% |
Q2 2016 | $408,000 | +31.2% | 9,024 | +19.1% | 0.15% | +30.4% |
Q1 2016 | $311,000 | – | 7,574 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |